A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2002
12/25/2002	CN1387576A Sequence-specific DNA recombination in ekaryotic cells
12/25/2002	CN1387571A Mammalian cytokines, related reagents and methods
12/25/2002	CN1387569A Apoptin-associating protein
12/25/2002	CN1387538A Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
12/25/2002	CN1387531A Pyrazolo [4,3-d] pyrimidine derivs.
12/25/2002	CN1387530A Imidazopyridine derivs. used as phosphodiesterase VII inhibitors
12/25/2002	CN1387528A Heterocyclic substd, pyrazolones
12/25/2002	CN1387526A Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof
12/25/2002	CN1387519A 2-imino-1,3-thiazine derivs.
12/25/2002	CN1387443A 联合疫苗组合物 Combined vaccine composition
12/25/2002	CN1387442A Oral recombinant lactobacilli vaccines
12/25/2002	CN1386754A Non-T cell conjugating peptide and its use
12/25/2002	CN1386544A Medicinally health-care powder made of ganoderma and lentinan
12/25/2002	CN1386521A Health regulator of human body
12/25/2002	CN1386510A Composition of suppressing infection, and veberage and food contg. same
12/25/2002	CN1097050C Substd 2,4-imidazolidinedione compounds and pharmaceutical active ingredients
12/24/2002	US6498274 Amide derivatives for the treatment of diseases mediated by cytokines
12/24/2002	US6498243 Epimorphin antagonist and process for producing it
12/24/2002	US6498233 Nucleic acid transfer system
12/24/2002	US6498178 Inhibitors of IMPDH enzyme
12/24/2002	US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis
12/24/2002	US6498162 Treating inflammatory and allergic diseases of respiratory tract and diseases of central nervous system
12/24/2002	US6498161 Treating infection by hiv; delaying of the onset of aids; asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis or rheumatoid arthritis
12/24/2002	US6498160 For therapy of emphysema, chronic bronchitis, asthma and allergic rhinitis
12/24/2002	US6498158 Il-5 inhibiting 6-azauracil derivatives
12/24/2002	US6498150 Low molecular weight cell, bone marrow and immune stimulants
12/24/2002	US6498148 Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host's antigen immune responsiveness to a Th1 phenotype
12/24/2002	US6497879 Composition which comprises isolated mage-10 tumor rejection antigen precursor which is encoded by nucleic acid having specified nucleotide sequence
12/24/2002	CA2172955C Liposomal defensins
12/24/2002	CA2150812C Catechol diethers as selective pde iv inhibitors
12/24/2002	CA2147863C Determination of peptide motifs on mhc molecules
12/24/2002	CA2086264C Surface complexed lymphotoxin
12/24/2002	CA2070182C Chimeric immunoglobulin for cd4 receptors
12/23/2002	WO2002094290A1 Use of lps for treating intestinal inflammation processes
12/23/2002	CA2414288A1 Use of lps in the treatment of intestinal inflammatory processes
12/19/2002	WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
12/19/2002	WO2002101008A2 Intracellular signaling molecules
12/19/2002	WO2002101005A2 A g-protein coupled receptor and uses therefor
12/19/2002	WO2002100889A1 Novel epitope of human papilloma virus e7 antigen and cd4-positive t cells activated by the epitope
12/19/2002	WO2002100888A1 Somatostatin-dopamine chimeric analogs
12/19/2002	WO2002100879A1 Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
12/19/2002	WO2002100859A1 Pde iv inhibitors
12/19/2002	WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002	WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections
12/19/2002	WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100833A1 Rho KINASE INHIBITORS
12/19/2002	WO2002100826A2 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
12/19/2002	WO2002100824A1 A novel alkaloid derivative and a pharmaceutical composition containing the same
12/19/2002	WO2002100812A1 Carboxylic acid derivative and salt thereof
12/19/2002	WO2002100437A2 Ophthalmic compositions comprising hyaluronic acid
12/19/2002	WO2002100416A1 Socs-5 molecules, screening therefore and therapeutic uses thereof
12/19/2002	WO2002100409A1 Antiinflammatoric and antitussive compositions
12/19/2002	WO2002100408A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
12/19/2002	WO2002100406A1 Use of yohimbine in the preparation of immunobiologically active drugs
12/19/2002	WO2002100405A1 Isoquinoline inhibitors of p38
12/19/2002	WO2002100354A2 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
12/19/2002	WO2002100351A2 A method for treating inflammatory diseases by administering a ppar-delta agonist
12/19/2002	WO2002100348A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
12/19/2002	WO2002100336A2 Tissue-specific endothelial membrane proteins
12/19/2002	WO2002100334A2 Use of radiopharmaceutical complexes in achieving transplantation tolerance
12/19/2002	WO2002100332A2 Isoxazoline compounds having mif antagonist activity
12/19/2002	WO2002100330A2 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
12/19/2002	WO2002100328A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	WO2002100327A2 Substituted 1-benzazepines and derivatives thereof
12/19/2002	WO2002100325A2 Polyvalent nanoparticles
12/19/2002	WO2002100148A2 Treatment or prophylaxis of insulin-producing cell graft rejection
12/19/2002	WO2002087583A3 Use of hiv-protease inhibitors to block cell migration and/or invasion, tissue infiltration and oedema formation
12/19/2002	WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors
12/19/2002	WO2002078684A3 Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
12/19/2002	WO2002074777A3 Pyranocoumarin compounds as a novel pharmacophore with anti-tb activity
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070515A3 Chromane derivatives, process for their preparation and their use as antitumor agents
12/19/2002	WO2002062370A9 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
12/19/2002	WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002	WO2002058681A3 Use of rhein for preparing a medicine for treating a high level of il-1
12/19/2002	WO2002055501A3 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
12/19/2002	WO2002011767A3 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
12/19/2002	WO2001077169A9 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
12/19/2002	WO2001070032A9 Recombinant parainfluenza virus expression systems and vaccines
12/19/2002	WO2001068859A9 Il-17 receptor like molecules and uses thereof
12/19/2002	US20020193634 Disulfide derivatives useful for treating allergic diseases
12/19/2002	US20020193633 Mast cell stabilizers
12/19/2002	US20020193614 Treatment of cardiovascular disorders
12/19/2002	US20020193612 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
12/19/2002	US20020193603 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
12/19/2002	US20020193601 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
12/19/2002	US20020193600 Preparing anhydrous 4-(4-(4-(Hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha- dimethylbenzene acetic acid hydrochloride by azeotropic distillation of the corresponding hydrate
12/19/2002	US20020193576 Mixture for use in the prevention and treatmenyt of infection
12/19/2002	US20020193571 Wsx receptor agonist antibodies
12/19/2002	US20020193570 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
12/19/2002	US20020193449 Lactam compounds for penetration enhancement
12/19/2002	US20020193420 Neurotrophic, low molecular weight, small molecule heterocyclic ketone or thioester compounds are nonimmunosuppressive, has an affinity for FKBP type immunophilins
12/19/2002	US20020193414 Adamantane derivatives
12/19/2002	US20020193396 Sulfonamido ether substituted imidazoquinolines
12/19/2002	US20020193357 Liver X receptor agonists
12/19/2002	US20020193333 For immunization for the therapy of diseases with or without combination chemotherapy
12/19/2002	US20020193306 Treatment of allergic rhinitis

1 ... 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 ... 1172